Show simple item record

dc.contributor.authorLaurens, Matthew B.
dc.date.accessioned2018-05-29T18:48:58Z
dc.date.available2018-05-29T18:48:58Z
dc.date.issued2018-04-18
dc.identifier.urihttp://hdl.handle.net/10713/7885
dc.descriptionPresented at the Multilateral Initiative on Malaria Pan African Malaria Conference in Dakar, Senegal in April 2018 on the behalf of the PfSPZ Vaccine in Burkina Faso study teamen_US
dc.description.sponsorshipNational Institutes of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under U01 AIl112367Ien_US
dc.language.isoen_USen_US
dc.subjectSanaria PfSPZ vaccineen_US
dc.subjectUniversity of Maryland, Baltimore. School of Medicine. Center for Vaccine Development and Global Healthen_US
dc.subject.meshBurkina Fasoen_US
dc.subject.meshMalaria Vaccinesen_US
dc.titleSafety, tolerablity and efficacy of a metabolically active, non-replicating, whole organism malaria vaccine (PfSPZ Vaccine) in malaria-experienced adults in Burkina Fasoen_US
dc.typePoster/Presentationen_US
refterms.dateFOA2019-02-19T18:08:25Z


Files in this item

Thumbnail
Name:
MultilateralInitiativeinMalari ...
Size:
11.50Mb
Format:
Microsoft PowerPoint 2007

This item appears in the following Collection(s)

Show simple item record